Literature DB >> 31534038

A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.

Adam Z Cheng1,2,3,4, Sofia N Moraes1,2,3,4, Claire Attarian1,2,3,4, Jaime Yockteng-Melgar5,6, Matthew C Jarvis1,2,3,4, Matteo Biolatti7, Ganna Galitska7, Valentina Dell'Oste7, Lori Frappier5, Craig J Bierle3,8, Stephen A Rice3,9, Reuben S Harris10,2,3,4,11.   

Abstract

An integral part of the antiviral innate immune response is the APOBEC3 family of single-stranded DNA cytosine deaminases, which inhibits virus replication through deamination-dependent and -independent activities. Viruses have evolved mechanisms to counteract these enzymes, such as HIV-1 Vif-mediated formation of a ubiquitin ligase to degrade virus-restrictive APOBEC3 enzymes. A new example is Epstein-Barr virus (EBV) ribonucleotide reductase (RNR)-mediated inhibition of cellular APOBEC3B (A3B). The large subunit of the viral RNR, BORF2, causes A3B relocalization from the nucleus to cytoplasmic bodies and thereby protects viral DNA during lytic replication. Here, we use coimmunoprecipitation and immunofluorescence microscopy approaches to ask whether this mechanism is shared with the closely related gammaherpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) and the more distantly related alphaherpesvirus herpes simplex virus 1 (HSV-1). The large RNR subunit of KSHV, open reading frame 61 (ORF61), coprecipitated multiple APOBEC3s, including A3B and APOBEC3A (A3A). KSHV ORF61 also caused relocalization of these two enzymes to perinuclear bodies (A3B) and to oblong cytoplasmic structures (A3A). The large RNR subunit of HSV-1, ICP6, also coprecipitated A3B and A3A and was sufficient to promote the relocalization of these enzymes from nuclear to cytoplasmic compartments. HSV-1 infection caused similar relocalization phenotypes that required ICP6. However, unlike the infectivity defects previously reported for BORF2-null EBV, ICP6 mutant HSV-1 showed normal growth rates and plaque phenotypes. Combined, these results indicate that both gamma- and alphaherpesviruses use a conserved RNR-dependent mechanism to relocalize A3B and A3A and furthermore suggest that HSV-1 possesses at least one additional mechanism to neutralize these antiviral enzymes.IMPORTANCE The APOBEC3 family of DNA cytosine deaminases constitutes a vital innate immune defense against a range of different viruses. A novel counterrestriction mechanism has recently been uncovered for the gammaherpesvirus EBV, in which a subunit of the viral protein known to produce DNA building blocks (ribonucleotide reductase) causes A3B to relocalize from the nucleus to the cytosol. Here, we extend these observations with A3B to include a closely related gammaherpesvirus, KSHV, and a more distantly related alphaherpesvirus, HSV-1. These different viral ribonucleotide reductases also caused relocalization of A3A, which is 92% identical to A3B. These studies are important because they suggest a conserved mechanism of APOBEC3 evasion by large double-stranded DNA herpesviruses. Strategies to block this host-pathogen interaction may be effective for treating infections caused by these herpesviruses.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  APOBEC3A; APOBEC3B; herpesviruses; innate antiviral immunity; ribonucleotide reductase

Mesh:

Substances:

Year:  2019        PMID: 31534038      PMCID: PMC6854502          DOI: 10.1128/JVI.01539-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  DNA deamination mediates innate immunity to retroviral infection.

Authors:  Reuben S Harris; Kate N Bishop; Ann M Sheehy; Heather M Craig; Svend K Petersen-Mahrt; Ian N Watt; Michael S Neuberger; Michael H Malim
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Inhibition of hepatitis B virus replication by APOBEC3G.

Authors:  Priscilla Turelli; Bastien Mangeat; Stephanie Jost; Sandrine Vianin; Didier Trono
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

3.  APOBEC3 proteins inhibit human LINE-1 retrotransposition.

Authors:  Heide Muckenfuss; Matthias Hamdorf; Ulrike Held; Mario Perkovic; Johannes Löwer; Klaus Cichutek; Egbert Flory; Gerald G Schumann; Carsten Münk
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

Review 4.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment.

Authors:  Michael H Malim; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

5.  APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.

Authors:  Daniel J Salamango; Jordan T Becker; Jennifer L McCann; Adam Z Cheng; Özlem Demir; Rommie E Amaro; William L Brown; Nadine M Shaban; Reuben S Harris
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

Review 6.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

7.  Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant.

Authors:  D J Goldstein; S K Weller
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

8.  Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.

Authors:  Rebecca S Larue; Joy Lengyel; Stefán R Jónsson; Valgerdur Andrésdóttir; Reuben S Harris
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

9.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

10.  Hypermutation of an ancient human retrovirus by APOBEC3G.

Authors:  Young Nam Lee; Michael H Malim; Paul D Bieniasz
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more
  11 in total

1.  G1/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B.

Authors:  Jaime Yockteng-Melgar; Kathy Shire; Adam Z Cheng; Natasha Malik-Soni; Reuben S Harris; Lori Frappier
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

2.  The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Atsuko Sugimoto; Yuichi Abe; Tadashi Watanabe; Kohei Hosokawa; Jun Adachi; Takeshi Tomonaga; Yasumasa Iwatani; Takayuki Murata; Masahiro Fujimuro
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

3.  Mutational pressure by host APOBEC3s more strongly affects genes expressed early in the lytic phase of herpes simplex virus-1 (HSV-1) and human polyomavirus (HPyV) infection.

Authors:  Maxwell Shapiro; Laurie T Krug; Thomas MacCarthy
Journal:  PLoS Pathog       Date:  2021-04-30       Impact factor: 6.823

4.  Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism of APOBEC3B inhibition.

Authors:  Nadine M Shaban; Rui Yan; Ke Shi; Sofia N Moraes; Adam Z Cheng; Michael A Carpenter; Jason S McLellan; Zhiheng Yu; Reuben S Harris
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

5.  Retroviruses drive the rapid evolution of mammalian APOBEC3 genes.

Authors:  Jumpei Ito; Robert J Gifford; Kei Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 6.  The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present.

Authors:  Keiya Uriu; Yusuke Kosugi; Jumpei Ito; Kei Sato
Journal:  Viruses       Date:  2021-01-17       Impact factor: 5.048

Review 7.  APOBECs and Herpesviruses.

Authors:  Adam Z Cheng; Sofia N Moraes; Nadine M Shaban; Elisa Fanunza; Craig J Bierle; Peter J Southern; Wade A Bresnahan; Stephen A Rice; Reuben S Harris
Journal:  Viruses       Date:  2021-02-28       Impact factor: 5.818

Review 8.  The Role of APOBECs in Viral Replication.

Authors:  Wendy Kaichun Xu; Hyewon Byun; Jaquelin P Dudley
Journal:  Microorganisms       Date:  2020-11-30

Review 9.  Human APOBEC3 Variations and Viral Infection.

Authors:  Shiva Sadeghpour; Saeideh Khodaee; Mostafa Rahnama; Hamzeh Rahimi; Diako Ebrahimi
Journal:  Viruses       Date:  2021-07-14       Impact factor: 5.818

10.  Inhibition of base editors with anti-deaminases derived from viruses.

Authors:  Zhiquan Liu; Siyu Chen; Liangxue Lai; Zhanjun Li
Journal:  Nat Commun       Date:  2022-02-01       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.